Summary
The newly identified platelet collagen receptor glycoprotein VI binds to fibrous collagen,
inducing platelet activation. Several antibodies against GPVI have been reported,
including a patient’s auto-antibodies, that activates platelets through their ability
to crosslink this glycoprotein. We have developed a monoclonal antibody (mAb) against
GPVI using the recombinant extracellular domain of GPVI as an antigen. This antibody,
mAb 204-11, induced platelet aggregation and tyrosine phosphorylation of proteins
similar to those induced by GPVI-reactive proteins, collagen and convulxin. Its interaction
with GPVI was analyzed by measuring the effect of the antibody on GPVI binding to
collagen using a dimeric form of recombinant GPVI, GPVI-Fc2. MAb 204-11 inhibited the binding of GPVI-Fc2 to fibrous collagen particles, but enhanced the GPVI binding to immobilized collagen,
suggesting that the antibody binds to a region near the collagen binding site of GPVI.
MAb 204-11 also inhibited the GPVI binding to convulxin at a low concentration, but
not completely. Since mAb 204-11 reacts specifically with GPVI and is applicable for
immunoblotting and immunoprecipitation, this antibody would be useful for studies
on GPVI.
Keywords
Platelet - GPVI - monoclonal antibody - collagen receptor - collagen